AtriCure (ATRC) Gross Profit (2010 - 2026)

AtriCure (ATRC) has 17 years of Gross Profit data on file, last reported at $109.3 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $109.3 million, up 18.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $417.5 million (up 16.32% YoY), and the FY2025 annual result was $400.8 million, up 15.32% from the prior year.
• Gross Profit rose to $109.3 million in Q1 2026 per ATRC's latest filing, from $105.3 million in the prior quarter.
• Over five years, Gross Profit peaked at $109.3 million in Q1 2026 and troughed at $55.6 million in Q1 2022.
• A 5-year average of $82.6 million and a median of $81.3 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2023 and 2024: Gross Profit grew 25.21% in 2023, then rose 12.67% in 2024.
• A 5-year view of Gross Profit shows it stood at $65.1 million in 2022, then grew by 22.58% to $79.8 million in 2023, then advanced by 16.04% to $92.6 million in 2024, then increased by 13.73% to $105.3 million in 2025, then gained by 3.77% to $109.3 million in 2026.
• Business Quant data shows ATRC's Gross Profit at $109.3 million in Q1 2026, $105.3 million in Q4 2025, and $101.3 million in Q3 2025.